FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TREXALL (methotrexate) filed by Teva Women's Health, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Choriocarcinoma
• Ectopic Pregnancy
• Non-hodgkin Lymphoma
• Osteosarcoma
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Trexall (Methotrexate)

Snippet

SUPPL AP for TREXALL (METHOTREXATE)